Table 1 Demographic and clinical characteristics of the studied samples.
Demographics (101 patients) | ||||
Age [X ± SD] | 58.36 ± 18.29 | |||
Age | ||||
Below 60 [%] | 44.6% | |||
Over 60 [%] | 54.5% | |||
Gender | ||||
Male [%] | 60.4% | |||
Female [%] | 39.6% | |||
Not reported [%] | 0% | |||
Race | ||||
Caucasian/Hispanic Latino [%] | 26.73% | |||
Black [%] | 63.37% | |||
Other/Asian/unknown [%] | 9.9% | |||
Pre-existing conditions | ||||
Charleston comorbidity index [X ± SD] | 3.49 ± 2.95 | |||
Acute coronary syndrome [%] | 4.95% | |||
Congestive heart failure [%] | 12.87% | |||
Peripheral vascular disease [%] | 6.93% | |||
Cerebrovascular disease/Transient ischemic attack [%] | 9.9% | |||
Dementia [%] | 3.96% | |||
Chronic obstructive pulmonary disease [%] | 11.88% | |||
Connective tissue disease [%] | 2.97% | |||
Peptic Ulcer Disease [%] | 2.97% | |||
Liver Disease [%] | 1.98% | |||
Diabetes mellites [%] | 35.64% | |||
Hemiplegia [%] | 3.96% | |||
Chronic kidney disease [%] | 24.75% | |||
Solid Tumor [%] | 10.89% | |||
Leukemia [%] | 0.99% | |||
Lymphoma [%] | 9.9% | |||
Acquired immunodeficiency syndrome [%] | 0% | |||
Smoker | ||||
Smoker [%] | 0.99% | |||
Former smoker [%] | 9.9% | |||
Non-smoker [%] | 56.44% | |||
Vaper [%] | 0% | |||
Mortality [%] | 15.84% | |||
Stroke [%] | 5.66% | |||
Length of stay [X ± SD] | 17.7 ± 26.65 | |||
Intensive care Unit [%] | 49.5% | |||
Intubated [%] | 32.67% | |||
Extra corporeal membrane oxygenation [%] | 8.91% | |||
APACHE admission + 1 h [X ± SD] | 10.72 ± 7.65 | |||
APACHE admission + 24 h [X ± SD] | 10.76 ± 7.18 | |||
Organ failures | H1 (%) | H2 (%) | H3 (%) | H4 (%) |
|---|---|---|---|---|
Central nervous system failure [%] | 8.91 | 4.95 | 6.93 | 6.93 |
Cardiovascular system failure [%] | 26.73 | 12.87 | 17.82 | 11.88 |
Respiratory failure [%] | 35.64 | 34.65 | 25.74 | 14.85 |
Renal failure (acute kidney injury) [%] | 22.77 | 13.86 | 14.85 | 7.92 |
Liver failure [%] | 42.57 | 26.73 | 23.76 | 10.89 |
